Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISTAMP: MMF Discontinuation in Kidney Transplant
NCT00693381Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2003
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial of mycophenolate mofetil in kidney transplant rejection (2 arms), sponsored by Astellas Pharma. Primary endpoint: Incidence of and time to first biopsy proven acute rejection at 6 months. Started Feb 2003; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00693381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693381.